BioMedReports: There has been some talk about the upcoming opening of your new state-of-the-art facility. Can you tell us about that?
CEO Matthew L. Schissler: We always try to focus on three core goals and in 2010 we are opening our new state of the art laboratory. One of those three core goals is the diversification of revenue streams. Not only will we have our own organic growth engine, by processing and storing for our own company, but we recently entered into a letter of agreement to process and store for another very successful stem cell company. That’s
Mesenchymal stem cells are present in placental blood and could represent the new frontier for tissue and organ regeneration. The cells were identified at the cell factory at Milan’s Policlinico Hospital and will be the subject of a meeting on mesenchymal stem cells organized by the Milan hospital.
Isolated and preserved in the Milan biobank for the first time for use in future treatments, the cells come from blood that is collected at birth. Plasma that has been used for transplants in patients with serious diseases like leukemia and lymphoma and represent a potential reserve of mesenchymal stem
Image via Wikipedia
Summit at Lake Como with 100 European stem cell experts.
At the summit, 16 research teams part of the Neurostemcell consortium that have been working for months on finding treatments for Parkinson’s and Huntington’s disease met. The network, coordinated by Elena Cattaneo, Director of Unistem, the interdepartmental stem cell research centre of the University of Milan, met on April 1 in Bellagio, on the shores of Lake Como for their first annual meeting.
“The meeting is an opportunity to discuss the results obtained until now and to refine our methods,” explained Cattaneo, who pointed out the objective of
A blood sample databank under the China Marrow Donor Program (CMDP), was officially established Monday at Zhongguancun of Beijing.
The new databank is now the largest for Chinese people in the world, according to Hong Junling, deputy head of CMDP management center.
The databank includes information such as the names and gender of nearly one million donors and information about to which ethnic groups the donors come from, Hong said.
It also covers such medical information as blood types, gene types and health status of the donors.
The CMDP, launched in 2001 by the Red Cross Society of China, aims to help millions